Waters

Waters EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Waters (WAT) as of Nov 12, 2026 is 21.63. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 23.86 — a change of -9.33% (lower).

EV/EBITDA

21.63

YoY

-9.33%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Waters is 2025 21.63 . EV/EBITDA (Enterprise Value to EBITDA) of Waters was 2024 23.86 . It decreases by -9.33% lower compared to the previous year.

The Waters EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
25.35 USD
Jan 1, 2019
29.07 USD
Jan 1, 2020
31.17 USD
Jan 1, 2021
24.71 USD
Jan 1, 2022
23.45 USD
Jan 1, 2023
25.28 USD
Jan 1, 2024
23.86 USD
Jan 1, 2025
21.63 USD
The Waters EV/EBITDA history
YEAREV/EBITDAYoY
21.63-9.33%
23.86-5.64%
25.28+7.82%
23.45-5.10%
24.71-20.72%
31.17+7.20%
29.07+14.69%
25.35-6.52%
27.12-7.18%
29.22-10.27%
32.56-9.16%
35.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Waters Stock analysis

What does Waters do? Waters Corporation is a leading company in the field of analytics and laboratory instruments. The company was founded in 1958 by James L. Waters and is headquartered in Milford, Massachusetts. Waters Corp originated from the development of liquid chromatography (LC), a technology that allows researchers to separate, identify and analyze substances in a sample. Over the years, Waters has built on this foundation and has evolved into a company that offers a wide range of solutions for the life science industry and chemical analysis. The business model of Waters Corp is based on the development and sale of innovative technologies and instruments for the analysis of chemical and biological substances. The company focuses on four main areas: life science mass spectrometry, chromatography, chemical analysis, and laboratory information systems. Life science mass spectrometry encompasses a range of technologies that facilitate the analysis of biological molecules and medical samples. Mass spectrometry is an instrument for measuring the mass of a molecule. It is used to determine the identity of compounds in a sample and provide information about their structure. Applications are diverse and range from the exploration of new drugs to the diagnosis of diseases. Chromatography systems allow researchers to split and identify substances in a sample. The company offers a wide range of solutions for liquid chromatography and gas chromatography, including systems for high-performance liquid chromatography (HPLC), ultra-high-performance liquid chromatography (UHPLC), and gas chromatography (GC). Chemical analysis encompasses a wide range of technologies that enable rapid, accurate, and reliable analysis of chemical substances. The company offers solutions for spectroscopy, nuclear magnetic resonance spectroscopy (NMR), and X-ray crystallography. Laboratory information systems enable effective management of laboratory information, including sample and result management, as well as report generation and data security. Waters offers solutions for laboratory information management systems (LIMS), electronic signature, and electronic archiving. The company has a wide range of products, including mass spectrometers, gas chromatographs, liquid chromatographs, laboratory information and chromatography software, accessories, and consumables. Waters' product range is focused on various applications in medical research, drug development, the food industry, environmental analysis, and other industries. Waters has a long history of innovation and has received numerous awards for its advancements in technology development and analytics. The company has become a global leader in analytical instruments, software products, and consumables, serving customers in more than 100 countries worldwide. Overall, Waters Corp has a strong position in the industry based on innovative technologies, broad performance spectrum, and decades of experience. The company is expected to continue playing an important role in the analytics and instruments industry, while focusing on the demand for accuracy, precision, and speed in the field of life science technology and chemistry. Waters is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Waters stock

EV/EBITDA (Enterprise Value to EBITDA) of Waters is 21.63 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Waters changed from 23.86 to 21.63, representing a -9.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Waters since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Waters with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Waters

All Key Metrics — Waters